Market opportunities in AI and ML for clinical trials include optimizing trial efficiency, predicting patient outcomes, and supporting adaptive trial designs, all while addressing regulatory and ...

Key factors driving this growth include the increasing need to lower drug development costs and timelines, the rising ...

Ai GPU Rental offers a more convenient way to access cloud GPUs , On-Demand GPU , and AI computing services. The idea is that ...

Discover 15 top tools like MoneyFlare and ChainGPT to automate your crypto and stock trades for passive income in 2026.

This week, the company (which, it should be noted, is owned by Rupert Murdoch’s Fox Corporation) decided to AI-ify by ...

Pionex is a popular choice for beginners looking to use AI trading bots without paying trading fees. The platform offers a ...

NEOS S&P 500 High Income ETF offers a 12%+ starting yield with monthly, tax-efficient distributions. Find out why SPYI is a ...

Standard monitoring systems are no longer enough to identify the silent killers lurking behind layers of operational ...

AccuQuant, a fintech company focused on quantitative trading technology, has officially launched its flagship AI-powered managed trading system for 2026. The company states that the system is powered ...

The U.S. For-Profit Hospitals Pricing National Database offers extensive pricing benchmarks for for-profit hospitals, providing opportunities for academic researchers, consultants, data analysts, and ...

In his keynote address, Prof. Sastry emphasized that AI is dramatically accelerating drug discovery timelines, reducing costs, and enabling precision-driven research outcomes.

Trent AI Ltd., a London-based artificial intelligence security startup, launched today with $13 million in seed funding. LocalGlobe and Cambridge Innovation Capital led the investment. They were ...